Want to see IN:ACUTAAS full AI Analyst Report?

Acutaas Chemicals (ACUTAAS) Price & Analysis

4 Followers

ACUTAAS Stock Chart & Stats

₹1747.20

-₹131.70(-5.63%)

At close: Jan 09 4:00 PM EST

₹1747.20

-₹131.70(-5.63%)

Day’s Range― - ―

52-Week Range₹1,085.75 - ₹3,606.50

Previous CloseN/A

VolumeN/A

Average Volume (3M)14.81K

Market Cap

₹292.59B

Enterprise Value₹243.71B

Total Cash (Recent Filing)₹2.80B

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)82.0

Beta1.38

Next Earnings

Aug 06, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.09%

Share Statistics

EPS (TTM)27.88

Shares Outstanding81,871,124

10 Day Avg. Volume15,850

30 Day Avg. Volume14,806

Financial Highlights & Ratios

PEG Ratio0.49

Price to Book (P/B)12.67

Price to Sales (P/S)15.64

P/FCF Ratio-733.99

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)52.91

Revenue Forecast (FY)₹17.54B

Bulls Say, Bears Say

Bulls Say

Recent Revenue And Margin ExpansionSharp FY2026 top-line and margin gains indicate meaningful operating leverage and/or a favorable product mix. Sustained higher margins improve internal cash generation capacity, support reinvestment and shareholder returns, and raise long-term profitability if the mix endures.

Conservative Balance SheetExtremely low reported leverage across the last two years materially reduces financial risk, giving management flexibility to fund growth, weather downturns, or pursue M&A without pressing refinancing needs. Capital structure strength supports durable credit resilience.

Improved Operating Cash GenerationOperating cash flow covering reported earnings signals better earnings quality and working-capital management in FY2026. Stronger cash conversion trends, if maintained, provide a foundation for funding capex and dividends and reduce reliance on external financing.

Bears Say

Consistent Negative Free Cash FlowPersistent negative free cash flow suggests the business requires ongoing heavy reinvestment or faces working-capital drains. Over time this can constrain balance sheet flexibility, limit debt reduction or payouts, and force external financing during cyclical stress.

Margin And Cash-flow VolatilityMaterial swings in margins and past negative operating cash flow indicate earnings sensitivity to mix, pricing, or costs. That volatility makes forecasting durable profit levels harder and raises the risk that recent strong results may not persist through industry cycles or input-cost shocks.

Historical Capital-structure VariabilityA prior sharp increase in leverage shows the company’s capital structure can change materially under certain conditions. This variability implies planning or funding choices could raise refinancing or covenant risk in adverse periods, reducing long-term financial predictability.

Acutaas Chemicals News

Tax Authority Conducts Search at Acutaas Chemicals’ Surat Facilities

The latest update is out from Acutaas Chemicals ( ($IN:ACUTAAS) ). Acutaas Chemicals disclosed that the Central Goods...

10d ago

Acutaas Chemicals Files SEBI Compliance Certificate, Reports No Demat Activity in Q4 FY26

The latest update is out from Acutaas Chemicals ( ($IN:ACUTAAS) ). Acutaas Chemicals Limited has submitted a compliance...

3M ago

ACUTAAS FAQ

What was Acutaas Chemicals Ltd’s price range in the past 12 months?

Acutaas Chemicals Ltd lowest stock price was ₹1085.75 and its highest was ₹3606.50 in the past 12 months.

What is Acutaas Chemicals Ltd’s market cap?

Acutaas Chemicals Ltd’s market cap is ₹292.59B.

When is Acutaas Chemicals Ltd’s upcoming earnings report date?

Acutaas Chemicals Ltd’s upcoming earnings report date is Aug 06, 2026 which is in 35 days.

How were Acutaas Chemicals Ltd’s earnings last quarter?

Acutaas Chemicals Ltd released its earnings results on Apr 30, 2026. The company reported ₹16.1 earnings per share for the quarter, beating the consensus estimate of ₹13.05 by ₹3.05.

Is Acutaas Chemicals Ltd overvalued?

According to Wall Street analysts Acutaas Chemicals Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Acutaas Chemicals Ltd pay dividends?

Acutaas Chemicals Ltd pays a Annually dividend of ₹1.5 which represents an annual dividend yield of 0.09%. See more information on Acutaas Chemicals Ltd dividends here

What is Acutaas Chemicals Ltd’s EPS estimate?

Acutaas Chemicals Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Acutaas Chemicals Ltd have?

Acutaas Chemicals Ltd has 81,871,124 shares outstanding.

What happened to Acutaas Chemicals Ltd’s price movement after its last earnings report?

Acutaas Chemicals Ltd reported an EPS of ₹16.1 in its last earnings report, beating expectations of ₹13.05. Following the earnings report the stock price went up 3.841%.

Which hedge fund is a major shareholder of Acutaas Chemicals Ltd?

Currently, no hedge funds are holding shares in IN:ACUTAAS

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Acutaas Chemicals Ltd

Based in Surat, India, Acutaas Chemicals Limited, founded in 2004, is engaged in the development, production, and global distribution of pharmaceutical intermediates. These crucial compounds are utilized in both regulated and generic active pharmaceutical ingredients (APIs) for a wide range of medical treatments, including those for anti-retroviral applications, inflammation, psychiatric conditions, cancer, Parkinson's disease, depression, and blood coagulation disorders. The company also produces a diverse portfolio of specialty chemicals, serving various industries such as battery manufacturing, personal care, agricultural chemicals, protective coatings, electronics, and general industrial processes. Notable offerings in this category include photoresist chemicals for semiconductor fabrication and electrolyte additives essential for lithium battery cells. Additionally, Acutaas Chemicals provides commodity chemicals like parabens and methyl salicylate, among other fine chemicals, which find application in cosmetics, agricultural products, and various chemical sectors. The company was previously known as Ami Organics Limited, changing its name to Acutaas Chemicals Limited in May 2025.